Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
May 18 2020 - 4:05PM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the
global, national and local relief efforts of our customers,
employees and communities, as we unite to combat COVID-19. Giving
back is in our DNA, and together with the Illumina Corporate
Foundation, we have committed more than $10M to support the
communities where we live and work. As we champion the greater
good, Illumina is focused on making sequencing accessible around
the world to fight the pandemic together through the power of
genomics, collaboration and global care for each other.
To support public health efforts associated with SARS-CoV-2
surveillance, sequencing and monitoring, Illumina, Inc. is
providing in kind donations valued at approximately $5M dollars for
instruments and consumables. In addition, we dedicated more than
$2M to COVID-19-related research efforts. To advance scientific
research, Illumina, Inc. recently released the SARS-CoV-2 Data
Toolkit, making it easier for researchers to detect and identify
the viral sequence in their samples and contribute their findings
to critical public databases. The toolkit is freely accessible on
BaseSpace Sequence Hub until October 2020.
“We will do everything we can to deliver next-generation
sequencing technology to power the scientists, researchers and
clinicians on the frontlines of the fight against COVID-19,” said
Francis deSouza, CEO of Illumina. “And, we will not stop there. In
addition to our technology, we are dedicated to making a positive
impact on humanity through our actions to empower our
communities.”
The Illumina Foundation has awarded more than $3M in
philanthropic donations, of which $1M has gone to the CDC
Foundation COVID Emergency Response Fund, and $2M to local
community-based initiatives in the areas where we operate.
“Every day that we are combatting this pandemic, I realize and
appreciate how each and every one us can help make a difference,”
said Judy Monroe, MD, President and CEO of the CDC Foundation. “The
Illumina Foundation’s generous donation will have a significant and
positive impact on fighting the coronavirus in communities across
the United States.”
The CDC Foundation is currently mobilized to support the Center
for Disease Control and Prevention’s response efforts, health
departments and others to fight the COVID-19 pandemic.
Native to Illumina’s San Diego
roots, the Illumina Foundation donated $1M to the San Diego
Foundation COVID-19 Community Response Fund to support distance
learning and connectivity for grades K-12, address food security
concerns and provide PPE for frontline healthcare professionals.
For more than 40 years, the San Diego Foundation has inspired
enduring philanthropy and enables community solutions to improve
quality of life.
“We are very honored that one of San
Diego’s most innovative and fastest growing companies has made a
generous commitment to ensuring San Diego school children have the
access they need to learn and grow while apart from their teachers
and schools,” shared Mark Stuart, President and CEO of The San
Diego Foundation.
"With the support of the Illumina Foundation, we have worked to
guarantee all students in San Diego have what they need to continue
their educational journey and pursue their dreams,” said Cindy
Marten, Superintendent of the San Diego Unified School District.
“The Illumina Foundation’s donation to the San Diego Foundation
will allow us to continue to provide our families the technology
and services they need to access information and to continue
learning now and into the future. We are very thankful for our
long-standing partnership with Illumina.”
Illumina employees have mobilized to take action by selecting
local initiatives in their respective communities to donate $1M to
their chosen organizations. Additionally, the Illumina Foundation
offered a special 200% giving match opportunity and our employees
showed an overwhelming response with more than $160,000 raised for
various organizations. In support of employees’ desire to directly
contribute to their communities, we expanded our paid volunteer
time off program from two to 10 days for 2020, and created a
directory of virtual volunteering options. Further, to support
distance learning, we are offering lessons, activities and videos
centered around genomics.
About Illumina, Inc.
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as the global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture and other emerging segments. To
learn more, visit www.illumina.com and follow @illumina.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200518005715/en/
Investors: Jacquie Ross, CFA 858-882-2172 ir@illumina.com
Media: Jen Carroll 858-449-8082 pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024